These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37084585)

  • 1. Identification of a novel extracellular inhibitor of FGF2/FGFR signaling axis by combined virtual screening and NMR spectroscopy approach.
    Pagano K; Listro R; Linciano P; Rossi D; Longhi E; Taraboletti G; Molinari H; Collina S; Ragona L
    Bioorg Chem; 2023 Jul; 136():106529. PubMed ID: 37084585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Basis of the Antiangiogenic Action of Rosmarinic Acid, a Natural Compound Targeting Fibroblast Growth Factor-2/FGFR Interactions.
    Pagano K; Carminati L; Tomaselli S; Molinari H; Taraboletti G; Ragona L
    Chembiochem; 2021 Jan; 22(1):160-169. PubMed ID: 32975328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches.
    Pagano K; Longhi E; Molinari H; Taraboletti G; Ragona L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.
    Marshall ME; Hinz TK; Kono SA; Singleton KR; Bichon B; Ware KE; Marek L; Frederick BA; Raben D; Heasley LE
    Clin Cancer Res; 2011 Aug; 17(15):5016-25. PubMed ID: 21673064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
    Sharpe R; Pearson A; Herrera-Abreu MT; Johnson D; Mackay A; Welti JC; Natrajan R; Reynolds AR; Reis-Filho JS; Ashworth A; Turner NC
    Clin Cancer Res; 2011 Aug; 17(16):5275-86. PubMed ID: 21712446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells.
    Hamamoto J; Yasuda H; Nonaka Y; Fujiwara M; Nakamura Y; Soejima K; Betsuyaku T
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1330-1334. PubMed ID: 30005872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signaling.
    Gupta AA; Chou RH; Li H; Yang LW; Yu C
    Biochim Biophys Acta; 2013 Dec; 1834(12):2606-19. PubMed ID: 24063890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.
    Akl MR; Nagpal P; Ayoub NM; Tai B; Prabhu SA; Capac CM; Gliksman M; Goy A; Suh KS
    Oncotarget; 2016 Jul; 7(28):44735-44762. PubMed ID: 27007053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors.
    Foglieni C; Pagano K; Lessi M; Bugatti A; Moroni E; Pinessi D; Resovi A; Ribatti D; Bertini S; Ragona L; Bellina F; Rusnati M; Colombo G; Taraboletti G
    Sci Rep; 2016 Mar; 6():23432. PubMed ID: 27000667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling.
    Herbert C; Schieborr U; Saxena K; Juraszek J; De Smet F; Alcouffe C; Bianciotto M; Saladino G; Sibrac D; Kudlinzki D; Sreeramulu S; Brown A; Rigon P; Herault JP; Lassalle G; Blundell TL; Rousseau F; Gils A; Schymkowitz J; Tompa P; Herbert JM; Carmeliet P; Gervasio FL; Schwalbe H; Bono F
    Cancer Cell; 2013 Apr; 23(4):489-501. PubMed ID: 23597563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
    Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM
    J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ShcA regulates neurite outgrowth stimulated by neural cell adhesion molecule but not by fibroblast growth factor 2: evidence for a distinct fibroblast growth factor receptor response to neural cell adhesion molecule activation.
    Hinsby AM; Lundfald L; Ditlevsen DK; Korshunova I; Juhl L; Meakin SO; Berezin V; Bock E
    J Neurochem; 2004 Nov; 91(3):694-703. PubMed ID: 15485499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational model of fibroblast growth factor-2 binding to endothelial cells under fluid flow.
    Patel NS; Reisig KV; Clyne AM
    Ann Biomed Eng; 2013 Jan; 41(1):154-71. PubMed ID: 22825797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs.
    Fons P; Gueguen-Dorbes G; Herault JP; Geronimi F; Tuyaret J; Frédérique D; Schaeffer P; Volle-Challier C; Herbert JM; Bono F
    J Cell Physiol; 2015 Jan; 230(1):43-51. PubMed ID: 24760775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.
    Brown WS; Tan L; Smith A; Gray NS; Wendt MK
    Mol Cancer Ther; 2016 Sep; 15(9):2096-106. PubMed ID: 27371729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation.
    Kostas M; Lampart A; Bober J; Wiedlocha A; Tomala J; Krowarsch D; Otlewski J; Zakrzewska M
    J Mol Biol; 2018 Oct; 430(21):4087-4101. PubMed ID: 30099027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
    Roskoski R
    Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.